AZAB MOHAMMAD
SEC insider (Form 3/4/5 filer). CIK 0001309653. Director at LISATA THERAPEUTICS, INC. (LSTA) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jan 9, 2026. Located in BASKING RIDGE, NJ.
Companies AZAB MOHAMMAD has filed insider reports for
- LISATA THERAPEUTICS, INC. (LSTA): Director
- DURECT CORP (DRRX): Director
AZAB MOHAMMAD
CIK: 0001309653
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jan 9, 2026LSTA
LISATA THERAPEUTICS, INC.
AwardDirect30.5K shares- - Sep 11, 2025DRRX
DURECT CORP
Tender OfferDirect6K shares- - Sep 11, 2025DRRX
DURECT CORP
DispositionDirectStock Option (right to buy)
7K shares- - Sep 11, 2025DRRX
DURECT CORP
DispositionDirectStock Option (right to buy)
2.8K shares- - Sep 11, 2025DRRX
DURECT CORP
DispositionDirectStock Option (right to buy)
5.5K shares- - Sep 11, 2025DRRX
DURECT CORP
DispositionDirectStock Option (right to buy)
5.5K shares- - Sep 11, 2025DRRX
DURECT CORP
DispositionDirectStock Option (right to buy)
5.5K shares- - Jan 9, 2025LSTA
LISATA THERAPEUTICS, INC.
AwardDirect15.8K shares- - Sep 25, 2024DRRX
DURECT CORP
AwardDirectStock Option (right to buy)
5.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 9, 2026 | LSTA LISATA THERAPEUTICS, INC. | Award | 30,456 | - | $0 | Direct |
| Sep 11, 2025 | DRRX DURECT CORP | Tender Offer | 6,000 | - | - | Direct |
| Sep 11, 2025 | DRRX DURECT CORP | Disposition Stock Option (right to buy) | 7,000 | - | - | Direct |
| Sep 11, 2025 | DRRX DURECT CORP | Disposition Stock Option (right to buy) | 2,750 | - | - | Direct |
| Sep 11, 2025 | DRRX DURECT CORP | Disposition Stock Option (right to buy) | 5,500 | - | - | Direct |
| Sep 11, 2025 | DRRX DURECT CORP | Disposition Stock Option (right to buy) | 5,500 | - | - | Direct |
| Sep 11, 2025 | DRRX DURECT CORP | Disposition Stock Option (right to buy) | 5,500 | - | - | Direct |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | Award | 15,789 | - | $0 | Direct |
| Sep 25, 2024 | DRRX DURECT CORP | Award Stock Option (right to buy) | 5,500 | - | - | Direct |
1-9 of 9 transactions